| Dr Brett E Igbinoba, OD | |
|
4330 Mitchell Way, Bellingham, WA 98226-9175 | |
| (360) 738-6860 | |
| (360) 738-6853 |
| Full Name | Dr Brett E Igbinoba |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 9 Years |
| Location | 4330 Mitchell Way, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548610066 | NPI | - | NPPES |
| 2062225 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD60601607 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Cataract And Laser Institute Inc Pc | 7517864119 | 73 |
| Pacific Cataract And Laser Institute Inc Pc | 7517864119 | 73 |
News Archive
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
A strengthened cement has been devised specifically for facial reconstructive surgery. Materials Scientists at the University of Birmingham's School of Dentistry have discovered that by adding sodium citrate to the liquid phase, calcium phosphate cement is more than three times stronger.
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.
› Verified 8 days ago
| Provider Name | Pacific Cataract And Laser Institute Inc Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306013925 PECOS PAC ID: 7517864119 Enrollment ID: O20040213000312 |
News Archive
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
A strengthened cement has been devised specifically for facial reconstructive surgery. Materials Scientists at the University of Birmingham's School of Dentistry have discovered that by adding sodium citrate to the liquid phase, calcium phosphate cement is more than three times stronger.
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.
› Verified 8 days ago
| Provider Name | Pacific Cataract And Laser Institute Inc Pc |
|---|---|
| Provider Type | Part B Supplier - Ambulatory Surgical Center |
| Provider Identifiers | NPI Number: 1659548329 PECOS PAC ID: 7517864119 Enrollment ID: O20120807000878 |
News Archive
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
A strengthened cement has been devised specifically for facial reconstructive surgery. Materials Scientists at the University of Birmingham's School of Dentistry have discovered that by adding sodium citrate to the liquid phase, calcium phosphate cement is more than three times stronger.
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.
› Verified 8 days ago
| Provider Name | Bridgeport Family Vision Clinic Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235517541 PECOS PAC ID: 6901113596 Enrollment ID: O20150915000703 |
News Archive
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
A strengthened cement has been devised specifically for facial reconstructive surgery. Materials Scientists at the University of Birmingham's School of Dentistry have discovered that by adding sodium citrate to the liquid phase, calcium phosphate cement is more than three times stronger.
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett E Igbinoba, OD Po Box 1506, Chehalis, WA 98532-0409 Ph: (360) 242-3008 | Dr Brett E Igbinoba, OD 4330 Mitchell Way, Bellingham, WA 98226-9175 Ph: (360) 738-6860 |
News Archive
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
A strengthened cement has been devised specifically for facial reconstructive surgery. Materials Scientists at the University of Birmingham's School of Dentistry have discovered that by adding sodium citrate to the liquid phase, calcium phosphate cement is more than three times stronger.
Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.
Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.
› Verified 8 days ago
Dr. Rajbir Kaur Khehra, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4540 Cordata Pkwy Ste 103, Bellingham, WA 98226 Phone: 360-676-8663 Fax: 360-676-8682 | |
Bryan T Redick, OD Optometrist Medicare: Medicare Enrolled Practice Location: 302 36th St, Bellingham, WA 98225 Phone: 360-363-0360 Fax: 360-363-0160 | |
Aleksey Shkurat Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1303 Cornwall Ave, Bellingham, WA 98225 Phone: 360-647-0421 Fax: 360-647-0469 | |
Dr. Cam My Ly, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4125 Arctic Ave, Bellingham, WA 98226 Phone: 360-812-7015 Fax: 360-812-7019 | |
Vision Plus Optometrist Medicare: Medicare Enrolled Practice Location: 2520 James St, Bellingham, WA 98225 Phone: 360-733-7393 Fax: 360-722-7785 | |
Dr. Hannah Margaret Joyner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 Birchwood Ave, Bellingham, WA 98225 Phone: 360-733-1720 Fax: 360-733-0109 | |
Rhonda Swanson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4420 Meridian St, Kulshan Eye Care, Bellingham, WA 98226 Phone: 360-647-0212 Fax: 360-647-2212 |